GPs, derived from Gynostemma pentaphyllum, alleviate hepatic steatosis and gut barrier damage in HFD-induced NAFLD models by activating the AMPK and TLR4/NF-κB pathways [71]. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.